Dilshad Ahmed Khan

Prof. Dilshad Ahmed Khan


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2022 in Complementary Therapies in Medicine
Verified
Journal Article
Open access
WMWajiha Mahjabeen
Wajiha Mahjabeen
DKDilshad Ahmed Khan
Dilshad Ahmed Khan
SMShakil Ahmed Mirza
Shakil Ahmed Mirza
The objective was to determine the effects of resveratrol supplementation on glucose homeostasis, oxidative stress, inflammation and microRNAs expression in patients with diabetes mellitus type 2 on oral hypoglycemic drugs. This was a randomized, double blinded placebo-controlled parallel group trial. The diabetic patients (n = 110) were randomly assigned either to resveratrol (n = 55) and placebo (55) groups after informed consent and given once daily resveratrol 200 mg and cellulose capsules respectively for 24 weeks. Fasting glucose, insulin, HbA1c, lipid profile, TNF- α, IL-6, hs-CRP, MDA & circulatory microRNAs were measured at start and end of 24- week intervention. Out of 110 patients recruited, 94 patients completed the study comprising of 45 in resveratrol and 46 in placebo group. The resveratrol supplementation after 24 weeks was resulted in significant reduction [mean difference (95%CI)] of plasma glucose[- 0.50(-0.94 to -0.06)], insulin[- 1.31(-2.24 to -0.38)], homeostatic model assessment of insulin resistance[- 0.83(-1.37 to -0.29)], malondialdehyde[- 0.36(-0.61 to -0.11)], high sensitive-C-reactive protein[- 0.35(-0.70 to -0.01)], tumor necrosis factor-alpha[- 1.25(-1.90 to -0.61)] and interleukin-6[- 1.99(-3.29 to -0.69)]. More than two-fold down regulation in miRNA-34a, miRNA-375, miRNA-21, miRNA-192 and up regulation in miRNA-126 and miRNA-132 expression was noted in patients receiving resveratrol as compared to placebo. No side effects were reported during the trial. Resveratrol supplementation contributes in improvement of glycemic control by reducing insulin resistance. It has significant beneficial impact on chronic inflammation, oxidative stress and associated microRNA expression in diabetic patients. Thus, supplementation of resveratrol along with oral hypoglycemic agents may be useful in the reduction of diabetic associated complications.

1 August 2020 in Complementary Therapies in Medicine
Verified
Journal Article
Closed access
MPMuhammad Amjad Pervez
Muhammad Amjad Pervez
DKDilshad Ahmed Khan
Dilshad Ahmed Khan
ASAtiq Ur Rehman Slehria
Atiq Ur Rehman Slehria
AIAamir Ijaz
Aamir Ijaz

18 January 2012 in Toxicology and Industrial Health
Verified
Journal Article
Closed access
PDF file
DKDilshad Ahmed Khan
Dilshad Ahmed Khan
SMShahida Mushtaq
Shahida Mushtaq
FKFarooq Ahmad Khan
Farooq Ahmad Khan
MKMuhammad Qaiser Alam Khan
Muhammad Qaiser Alam Khan
Chromium is widely used in the leather industry, and tannery workers are under constant threat of adverse health effects due to its excessive exposure. Our objective was to find out the toxic effects of chromium on tannery workers at Sialkot, Pakistan. A total of 240 males consisting of 120 workers from tanneries at Sialkot and equal number of controls were included. Blood complete counts, high-sensitive C-reactive protein, malondialdehyde and routine biochemical tests were carried out by routine procedures. Chromium levels in blood (BCr) and urine were analyzed using graphite furnace atomic absorption spectrophotometer Perkin Elmer analyst-200. Results revealed that all the workers were male with average age of 33 years and 15 (13%) had skin rashes, 14 (12%) had chronic bronchitis, 10 (8%) had gastritis and 4 (3%) conjunctivitis. The tannery workers had significantly raised median (interquartile range) of BCr 569 (377–726) nmol/L as compared to 318 (245–397) nmol/L in the control (p < 0.001). Sixty-five (54%) workers had BCr levels above the upper limit set by Agency for Toxic Substance and Drug Registry. The urinary chromium excretion was significantly high in workers 131 (46–312) nmol/L as compared to 13 (3–26) nmol/L in controls (p < 0.01). The workers had hematological, hepatic and renal function impairment because of oxidative stress on body systems. It is concluded that about half of the workers had excessive exposure to chromium in the tanneries at Sialkot. They had significantly raised chromium levels in their biological fluids and adverse health effects due to enhanced oxidative stress and inflammatory changes.

3 August 2022 in Complementary Therapies in Medicine
Verified
Journal Article
Open access
MPMuhammad Amjad Pervez
Muhammad Amjad Pervez
DKDilshad Ahmed Khan
Dilshad Ahmed Khan
SMShakeel Ahmed Mirza
Shakeel Ahmed Mirza
ASAtiq Ur Rehman Slehria
Atiq Ur Rehman Slehria
UNUzma Nisar
Uzma Nisar
MAMohammad Aamir
Mohammad Aamir
We aimed to compare the efficacy of δ-tocotrienol with α-tocopherol in the treatment of patients with non-alcoholic fatty liver disease (NAFLD). This study was a double-blinded, active-controlled trial. The patients with NAFLD were randomly assigned to receive either δ-tocotrienol 300 mg or α-tocopherol 268 mg twice daily for 48 weeks. The primary endpoints were change from baseline in fatty liver index (FLI), liver-to-spleen attenuation ratio (L/S ratio), and homeostatic model assessment for insulin resistance (HOMA-IR) at 48 weeks. Key secondary endpoints were change in markers of inflammation, oxidative stress, and hepatocyte apoptosis. Clinical assessment, biochemical analysis, and computed tomography scan of the liver were conducted at baseline, 24 and 48 weeks. A total of 100 patients (δ-tocotrienol = 50, α-tocopherol = 50) were randomized and included in the intention to treat analysis. Compared with baseline, there was a significant improvement (p < .001) in FLI, L/S ratio, HOMA-IR, and serum malondialdehyde in both groups at 48 weeks that was not significant between the two groups. However, there was a significantly greater decrease in body weight, serum interleukin-6, tumor necrosis factor-alpha, leptin, cytokeratin-18, and increase in adiponectin in the δ-tocotrienol group compared to the α-tocopherol group at 48 weeks (p < .05). No adverse events were reported. δ-tocotrienol and α-tocopherol exerted equally beneficial effects in terms of improvement in hepatic steatosis, oxidative stress, and insulin resistance in patients with NAFLD. However, δ-tocotrienol was more potent than α-tocopherol in reducing body weight, inflammation, and apoptosis associated with NAFLD. TRIAL REGISTRATION: Sri Lankan Clinical Trials Registry (https://slctr.lk/SLCTR/2019/038).

25 April 2021 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
WMWajiha Mahjabeen
Wajiha Mahjabeen
DKDilshad Ahmed Khan
Dilshad Ahmed Khan
SMShakeel Ahmed Mirza
Shakeel Ahmed Mirza
MPMuhammad Amjad Pervez
Muhammad Amjad Pervez

1 February 2012
Verified
Journal Article
Closed access
SGSyed Tanveer Abbas Gilani
Syed Tanveer Abbas Gilani
DKDilshad Ahmed Khan
Dilshad Ahmed Khan
FKFarooq Ahmad Khan
Farooq Ahmad Khan
MAMushtaq Ahmed
Mushtaq Ahmed